{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:46:18Z","timestamp":1789159578573,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.euroneuro.2026.112802","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:36:01Z","timestamp":1773304561000},"page":"112802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: A systematic review and meta-analysis of clinical and functional outcomes"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8589-7384","authenticated-orcid":false,"given":"Natalia E.","family":"Fares-Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-0220","authenticated-orcid":false,"given":"Yuki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Sijbrandij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-4352","authenticated-orcid":false,"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5497-2743","authenticated-orcid":false,"given":"Pim","family":"Cuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Harrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5118-786X","authenticated-orcid":false,"given":"Soraya","family":"Seedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0001","doi-asserted-by":"crossref","first-page":"pyaf023","DOI":"10.1093\/ijnp\/pyaf023","article-title":"Addressing blinding in classic psychedelic studies with innovative active placebos","volume":"28","author":"Aday","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0002","doi-asserted-by":"crossref","DOI":"10.1080\/20008066.2025.2485513","article-title":"Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder","volume":"16","author":"Agin-Liebes","year":"2025","journal-title":"Eur. J. Psychotraumatol."},{"issue":"9619","key":"10.1016\/j.euroneuro.2026.112802_bib0003","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(08)60505-X","article-title":"EQUATOR: reporting guidelines for health research","volume":"371","author":"Altman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0004","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based. Ment. Health"},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112802_bib0006","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0033291715001981","article-title":"The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium","volume":"46","author":"Benjet","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2022.102576","article-title":"Functional outcomes from psychotherapy for people with posttraumatic stress disorder: a meta-analysis","volume":"89","author":"Bonfils","year":"2022","journal-title":"J. Anxiety. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I2 is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res. Synth. Methods"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112802_bib0009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","article-title":"MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder","volume":"40","author":"Bouso","year":"2008","journal-title":"J Psychoact. Drugs"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0010","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)","first-page":"2023","article-title":"Chapter 7: considering bias and conflicts of interest among the included studies","author":"Boutron","year":"2023"},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112802_bib0011","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamapsychiatry.2022.0665","article-title":"Toward risk:benefit assessments in Psychedelic- and MDMA-assisted therapies","volume":"79","author":"Bradberry","year":"2022","journal-title":"JAMa Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpsychires.2022.03.008","article-title":"MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD","volume":"149","author":"Brewerton","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0013","doi-asserted-by":"crossref","unstructured":"Briere, & Runtz. (2002). The Inventory of Altered Self-Capacities (IASC): a standardized measure of identity, affect regulation, and relationship disturbance. Assessment., 9(3). doi:10.1177\/1073191102009003002.","DOI":"10.1177\/1073191102009003002"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0014","doi-asserted-by":"crossref","unstructured":"Carlson, E.B., & Putnam, F.W. (2022). Dissociative experiences scale-II [Data set]. doi:10.1037\/t86316-000.","DOI":"10.1037\/t86316-000"},{"issue":"8","key":"10.1016\/j.euroneuro.2026.112802_bib0015","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41386-024-01865-8","article-title":"Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis","volume":"49","author":"Colcott","year":"2024","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2026.112802_bib0016","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapsychiatry.2024.2887","article-title":"The psychotherapy in MDMA-assisted psychotherapy","volume":"81","author":"Cristea","year":"2024","journal-title":"JAMa Psychiatry"},{"issue":"10","key":"10.1016\/j.euroneuro.2026.112802_bib0017","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1021\/acschemneuro.8b00155","article-title":"Dark Classics in Chemical Neuroscience: 3,4-methylenedioxymethamphetamine","volume":"9","author":"Dunlap","year":"2018","journal-title":"ACS. Chem. Neurosci."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euroneuro.2025.08.003","article-title":"Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: a systematic review and meta-analysis","volume":"100","author":"Fares-Otero","year":"2025","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0019","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euroneuro.2024.07.002","article-title":"Childhood maltreatment: a call for a standardised definition and applied framework","volume":"87","author":"Fares-Otero","year":"2024","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112802_bib0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/a0015808","article-title":"An effect size primer: a guide for clinicians and researchers","volume":"40","author":"Ferguson","year":"2009","journal-title":"Prof. Psychol.: Res. Pract."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0021","first-page":"110","article-title":"The Posttraumatic Stress Disorder (PTSD) checklist for DSM\u20135: a systematic review of existing psychometric evidence","volume":"30","author":"Forkus","year":"2023","journal-title":"Clin. Psychol. : Publ. Div. Clin. Psychol. Am. Psychol. Assoc."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0022","doi-asserted-by":"crossref","unstructured":"Guyatt, G., Wang, Y., Eachempati, P., Iorio, A., Murad, M.H., Hultcrantz, M., Chu, D.K., Florez, I.D., Hemkens, L.G., Agoritsas, T., Yao, L., Vandvik, P.O., Montori, V.M., & Brignardello-Petersen, R. (2025). Core GRADE 4: rating certainty of evidence\u2014Risk of bias, publication bias, and reasons for rating up certainty. doi:10.1136\/bmj-2024-083864.","DOI":"10.1136\/bmj-2024-083864"},{"issue":"10","key":"10.1016\/j.euroneuro.2026.112802_bib0023","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41591-021-01525-0","article-title":"Challenges with benchmarking of MDMA-assisted psychotherapy","volume":"27","author":"Halvorsen","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0024","series-title":"Doing Meta-Analysis in R: A Hands-on Guide","author":"Harrer","year":"2022"},{"issue":"7","key":"10.1016\/j.euroneuro.2026.112802_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmen.0000347","article-title":"Standardized effect sizes are far from \u201cStandardized\u201d: a primer and empirical illustration in depression psychotherapy meta-analyses","volume":"2","author":"Harrer","year":"2025","journal-title":"PLOS Ment. Health"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2023-300978","article-title":"Understanding effect size: an international online survey among psychiatrists, psychologists, physicians from other medical specialities, dentists and other health professionals","volume":"27","author":"Heimke","year":"2024","journal-title":"BMJ Ment. Health"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/maq.12548","article-title":"MDMA is not ecstasy: the production of pharmaceutical safety through documents in clinical trials","volume":"35","author":"Hendy","year":"2021","journal-title":"Med Anthr. Q"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0028","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13063-017-1870-2","article-title":"Why clinical trial outcomes fail to translate into benefits for patients","volume":"18","author":"Heneghan","year":"2017","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.euroneuro.2026.112802_bib0029","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/sim.1752","article-title":"Controlling the risk of spurious findings from meta-regression","volume":"23","author":"Higgins","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0030","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)","first-page":"2024","author":"Higgins","year":"2024"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.euroneuro.2025.09.011","article-title":"Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: a living systematic review with meta-analysis","volume":"101","author":"H\u00f8jlund","year":"2025","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0032","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2024_529","article-title":"Psychedelic harm reduction and integration: a transtheoretical model for clinical practice","author":"Hu","year":"2024","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116586","article-title":"Prevalence of complex post-traumatic Stress disorder (CPTSD): a systematic review and meta-analysis","volume":"351","author":"Huynh","year":"2025","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112802_bib0034","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269881120965915","article-title":"A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: a systematic review and meta-analysis","volume":"35","author":"Illingworth","year":"2021","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2025.3019","article-title":"Serial ketamine infusions as adjunctive therapy to inpatient care for depression: the KARMA-Dep 2 randomized clinical trial","author":"Jelovac","year":"2025","journal-title":"JAMa Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112802_bib0036","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/00048674221083868","article-title":"A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders","volume":"57","author":"Kisely","year":"2023","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.661233","article-title":"Does psychedelic therapy have a transdiagnostic action and prophylactic potential?","volume":"12","author":"Ko\u010d\u00e1rov\u00e1","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"13","key":"10.1016\/j.euroneuro.2026.112802_bib0038","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1017\/S0033291717000708","article-title":"Posttraumatic stress disorder in the World Mental Health Surveys","volume":"47","author":"Koenen","year":"2017","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295926","article-title":"Effects of MDMA-assisted therapy for PTSD on self-experience","volume":"19","author":"Kolk van der","year":"2024","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1192\/bjp.2025.51","article-title":"Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness","volume":"227","author":"Lehrner","year":"2025","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112802_bib0041","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2190\/T8EM-C8YH-373N-1UWD","article-title":"Assessing psychiatric impairment in primary care with the Sheehan Disability Scale","volume":"27","author":"Leon","year":"1997","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0042","doi-asserted-by":"crossref","first-page":"q1798","DOI":"10.1136\/bmj.q1798","article-title":"MDMA assisted therapy: three papers are retracted as FDA rejects PTSD application","volume":"386","author":"Mahase","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0043","first-page":"25","article-title":"The safety and efficacy of {\u00b1}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","author":"Mithoefer","year":"2011","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0044","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112802_bib0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cpr.2009.01.005","article-title":"The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research","volume":"29","author":"McKnight","year":"2009","journal-title":"Clin. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0046","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S2045796018000343","article-title":"Contemporary approaches in mental health rehabilitation","volume":"28","author":"Meer van der","year":"2019","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0047","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/PROM.S156279","article-title":"The importance of patient-reported outcomes in clinical trials and strategies for future optimization","volume":"9","author":"Mercieca-Bebber","year":"2018","journal-title":"Patient. Relat. Outcome Meas."},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112802_bib0049","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med"},{"issue":"10","key":"10.1016\/j.euroneuro.2026.112802_bib0050","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112802_bib0051","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0052","first-page":"233","article-title":"The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD","author":"Nicholas","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.863088","article-title":"Entactogens: how the name for a novel class of psychoactive agents originated","volume":"13","author":"Nichols","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0054","first-page":"27","article-title":"A randomized, controlled pilot study of MDMA (\u00b1 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)","author":"Oehen","year":"2013","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"12","key":"10.1016\/j.euroneuro.2026.112802_bib0055","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0269881118806297","article-title":"3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial","volume":"32","author":"Ot\u2019alora G","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0056","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113514","article-title":"The effect of loneliness on distinct health outcomes: a comprehensive review and meta-analysis","volume":"294","author":"Park","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0058","unstructured":"Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., Britten, N., Roen, K., & Duffy, S. (2006). Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. doi:10.13140\/2.1.1018.4643."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0059","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin. Epidemiol. Glob. Health"},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112802_bib0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and Psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0061","series-title":"Psychedelic Drugs: Considerations for Clinical Investigations","author":"Research","year":"2023"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v093.i06","article-title":"Bayesian random-effects meta-analysis using the bayesmeta R Package","volume":"93","author":"R\u00f6ver","year":"2020","journal-title":"J. Stat. Softw."},{"issue":"8","key":"10.1016\/j.euroneuro.2026.112802_bib0063","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/0269881117715596","article-title":"Who is \u2018Molly\u2019? MDMA adulterants by product name and the impact of harm-reduction services at raves","volume":"31","author":"Saleemi","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112802_bib0064","doi-asserted-by":"crossref","DOI":"10.1097\/PSY.0b013e31803146d8","article-title":"Physical and mental comorbidity, disability, and suicidal behavior associated with posttraumatic stress disorder in a large community sample","volume":"69","author":"Sareen","year":"2007","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110843","article-title":"MDMA-assisted psychotherapy for PTSD: growing evidence for memory effects mediating treatment efficacy","volume":"128","author":"Sarmanlu","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"15","key":"10.1016\/j.euroneuro.2026.112802_bib0066","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1017\/S0033291724002319","article-title":"Posttraumatic stress disorder (PTSD) prevalence: an umbrella review","volume":"54","author":"Schincariol","year":"2024","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0067","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176210","article-title":"Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research","volume":"12","author":"Schmucker","year":"2017","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0068","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/npr2.12485","article-title":"MDMA-assisted psychotherapy for the treatment of PTSD: a systematic review and meta-analysis of randomized controlled trials (RCTs)","volume":"44","author":"Shahrour","year":"2024","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/jts.20497","article-title":"Posttraumatic stress disorder symptoms and functional impairment among OEF and OIF National Guard and Reserve veterans","volume":"23","author":"Shea","year":"2010","journal-title":"J. Trauma Stress."},{"issue":"Suppl 20","key":"10.1016\/j.euroneuro.2026.112802_bib0070","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0071","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40263-025-01162-y","article-title":"MDMA-assisted Therapy for Post-traumatic Stress Disorder: regulatory challenges and a path forward","volume":"39","author":"Singh","year":"2025","journal-title":"CNS. Drugs"},{"issue":"12","key":"10.1016\/j.euroneuro.2026.112802_bib0072","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1176\/appi.ajp.20230950","article-title":"Novel pharmacologic and other somatic treatment approaches for Posttraumatic stress disorder in adults: state of the evidence","volume":"181","author":"Sippel","year":"2024","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2026.112802_bib0073","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0327778","article-title":"MDMA-assisted therapy and current treatment options for chronic, treatment-resistant, moderate or higher severity post-traumatic stress disorder: systematic literature review","volume":"20","author":"Stanicic","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0074","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112802_bib0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size\u2014Or why the P value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J Gr. Med Educ"},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112802_bib0076","first-page":"512","article-title":"Expectancy effects in psychedelic trials","volume":"9","author":"Szigeti","year":"2024","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0077","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-14-30","article-title":"Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?","volume":"14","author":"Takeshima","year":"2014","journal-title":"BMC. Med. Res. Methodol."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0078","article-title":"Therapeutic frameworks in integration sessions in substance-assisted psychotherapy: a systematised review","author":"Thal","year":"2023","journal-title":"Clin. Psychol. PsychOther"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0079","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231198466","article-title":"History repeating: guidelines to address common problems in psychedelic science","volume":"13","author":"van Elk","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Res. Synth. Methods"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112802_bib0081","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and efficiency of meta-analytic variance estimators in the random-effects model","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J. Educ. Behav. Stat."},{"key":"10.1016\/j.euroneuro.2026.112802_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112802_bib0083","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/13645579.2021.1922805","article-title":"The influence of unpublished studies on results of recent meta-analyses: publication bias, the file drawer problem, and implications for the replication crisis","volume":"25","author":"Wagner","year":"2022","journal-title":"Int. J. Soc. Res. Methodol.: Theory Pract."},{"issue":"8","key":"10.1016\/j.euroneuro.2026.112802_bib0084","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881117711712","article-title":"Therapeutic effect of increased openness: investigating mechanism of action in MDMA-assisted psychotherapy","volume":"31","author":"Wagner","year":"2017","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112802_bib0085","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jval.2015.08.006","article-title":"Clinical Outcome Assessments: conceptual Foundation\u2014Report of the ISPOR Clinical Outcomes Assessment \u2013 Emerging Good Practices for Outcomes Research Task Force","volume":"18","author":"Walton","year":"2015","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112802_bib0086","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pas0000486","article-title":"The clinician-administered PTSD scale for DSM\u20135 (CAPS-5): development and Initial psychometric evaluation in military veterans","volume":"30","author":"Weathers","year":"2017","journal-title":"Psychol. Assess."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0087","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/psymed.2023.0028","article-title":"A systematic review of study design and placebo controls in psychedelic research","volume":"2","author":"Wen","year":"2024","journal-title":"Psychedelic Med. (New Rochelle N.Y.)"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.infsof.2022.106908","article-title":"Successful combination of database search and snowballing for identification of primary studies in systematic literature studies","volume":"147","author":"Wohlin","year":"2022","journal-title":"Inf. Softw. Technol."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112802_bib0089","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.ajp.20230681","article-title":"MDMA and MDMA-assisted therapy","volume":"182","author":"Wolfgang","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0090","series-title":"CIM-10\/ICD-10 : Classification Internationale Des Maladies. Dixi\u00e8me R\u00e9vision. Chapitre V(F) : Troubles Mentaux Et Troubles Du Comportement : Crit\u00e8res Diagnostiques Pour La Recherche","article-title":"The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research","year":"1993"},{"key":"10.1016\/j.euroneuro.2026.112802_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115886","article-title":"Efficacy and safety of psychedelics for the treatment of mental disorders: a systematic review and meta-analysis","volume":"335","author":"Yao","year":"2024","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0092","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/00048674251315642","article-title":"Safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in post-traumatic stress disorder: an overview of systematic reviews and meta-analyses","volume":"59","author":"Yong","year":"2025","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112802_bib0093","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1570159X22666231027111147","article-title":"The psychedelic future of Post-traumatic Stress disorder treatment","volume":"22","author":"Zaretsky","year":"2023","journal-title":"Curr. Neuropharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2600043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2600043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:19Z","timestamp":1787021059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X2600043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":92,"alternative-id":["S0924977X2600043X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112802","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: A systematic review and meta-analysis of clinical and functional outcomes","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112802"}}